U
Veradermics, Incorporated MANE
$103.90 -$4.23-3.91% NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
--
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2025
Total Cash And Short-Term Investments 167.24%
Total Receivables -8.73%
Inventory --
Prepaid Expenses 440.37%
Finance Division Loans and Leases Current --
Total Finance Division Other Current Assets --
Other Current Assets 9,815.79%
Total Current Assets 174.59%

Total Current Assets 174.59%
Net Property, Plant & Equipment --
Long-term Investments --
Goodwill --
Total Other Intangibles --
Finance Div Loans & Leases LT --
Total Finance Div Other LT Assets --
Total Other Assets --
Total Assets 174.82%

Total Accounts Payable -5.43%
Total Accrued Expenses 182.55%
Short-term Debt --
Current Portion of Long-Term Debt/Capital Leases --
Finance Division Debt Current --
Total Finance Division Other Current Liabilities --
Total Other Current Liabilities --
Total Current Liabilities 93.98%

Total Current Liabilities 93.98%
Long-Term Debt --
Short-term Debt --
Capital Leases --
Finance Division Debt Non Current --
Total Finance Division Other Non Current Liabilities --
Total Other Liabilities --
Total Liabilities 94.07%

Common Stock & APIC 212.52%
Retained Earnings -150.70%
Treasury Stock & Other 53.51%
Total Common Equity -134.79%

Preferred Stock Redeemable --
Preferred Stock Non Redeemable --
Preferred Stock Convertible 158.21%
Preferred Stock, Others --
Total Preferred Equity 158.21%

Total Common Equity -134.79%
Total Preferred Equity 158.21%
Total Minority Interest --
Total Equity 182.31%